Achievements and challenges of proteomics in the study of rheumatoid arthritis

Current Topics in Medicinal Chemistry

Volumn 13, Issue 6, 2013, Pages 732-742

  Ruiz Romero, Cristina ^a,b   Blanco, Francisco J ^a,c  

^a INIBIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c NONE   (Spain)

Author keywords

Biomarkers; Mass spectrometry; Protein arrays; Proteomics; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CERTOLIZUMAB PEGOL; ETANERCEPT; GOLIMUMAB; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INFLIXIMAB; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB;

ARTICLE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PATHOGENESIS; PROTEIN PROCESSING; PROTEOMICS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; HUMANS; PROTEOMICS;

EID: 84878780667     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611313060006     Document Type: Article

References (104)

1. Su, L. F. Updates on high-throughput molecular profiling for the study of rheumatoid arthritis. Isr. Med. Assoc. J., 2008, 10(4), 307-9.
2. Yamamoto, K.; Yamada, R. Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritis. J. Autoimmun., 2005, 25 Suppl, 12-5.
3. Toonen, E. J.; Barrera, P.; Radstake, T. R.; van Riel, P. L.; Scheffer, H.; Franke, B.; Coenen, M. J. Gene expression profiling in rheumatoid arthritis: current concepts and future directions. Ann. Rheum. Dis., 2008, 67(12), 1663-9.
4. Suzuki, A.; Kochi, Y.; Okada, Y.; Yamamoto, K. Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis. FEBS Lett., 2011, 585(23), 3627-32.
5. Tilleman, K.; Deforce, D. Proteomics in rheumatology. Expert Rev. Proteomics, 2008, 5(6), 755-9.
6. Vanarsa, K.; Mohan, C. Proteomics in rheumatology: the dawn of a new era. F1000 Med. Rep., 2010, 2, 87.
7. Ruiz-Romero, C.; Blanco, F.J. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Osteoarthritis Cartilage, 2010, 18(4), 500-509.
8. Ruiz-Romero, C.; Blanco, F.J. The role of proteomics in osteoarthritis pathogenesis research. Curr. Drug Targets, 2009, 10(6), 543-556.
9. Cox, J.; Mann, M. Is proteomics the new genomics? Cell, 2007, 130(3), 395-8.
10. rd. Proteomics for biological discovery; John Wiley & Sons: New York, 2006.
11. Neuhoff, V.; Arold, N.; Taube, D.; Ehrhardt, W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis, 1988, 9(6), 255-62.
12. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem., 1996, 68(5), 850-8.
13. White, I. R.; Pickford, R.; Wood, J.; Skehel, J. M.; Gangadharan, B.; Cutler, P. A statistical comparison of silver and SYPRO Ruby staining for proteomic analysis. Electrophoresis, 2004, 25(17), 3048-54.
14. Berger, K.; Wissmann, D.; Ihling, C.; Kalkhof, S.; Beck-Sickinger, A.; Sinz, A.; Paschke, R.; Fuhrer, D. Quantitative proteome analysis in benign thyroid nodular disease using the fluorescent ruthenium II tris(bathophenanthroline disulfonate) stain. Mol. Cell. Endocrinol., 2004, 227(1-2), 21-30.
15. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature, 2003, 422(6928), 198-207.
16. Unlu, M.; Morgan, M. E.; Minden, J. S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis, 1997, 18(11), 2071-7.
17. Lilley, K. S.; Friedman, D. B. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev. Proteomics, 2004, 1(4), 401-9.
18. Marouga, R.; David, S.; Hawkins, E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem., 2005, 382(3), 669-78.
19. Minden, J. Comparative proteomics and difference gel electrophoresis. Biotechniques, 2007, 43(6), 739, 741, 743 passim.
20. Fernandez-Costa, C.; Calamia, V.; Fernandez-Puente, P.; Capelo-Martinez, J. L.; Ruiz-Romero, C.; Blanco, F.J. Sequential depletion of human serum for the search of osteoarthritis biomarkers. Proteome Sci., 2012, 10(1), 55.
21. rd. Multidimensional separations for protein/peptide analysis in the post-genomic era. Biotechniques, 2002, 32(4), 898, 900, 902 passim.
22. Washburn, M. P. Utilisation of proteomics datasets generated via multidimensional protein identification technology (MudPIT). Brief Funct. Genomic. Proteomic., 2004, 3(3), 280-6.
23. Fournier, M. L.; Gilmore, J. M.; Martin-Brown, S. A.; Washburn, M. P. Multidimensional separations-based shotgun proteomics. Chem. Rev., 2007, 107(8), 3654-86.
24. DeSouza, L.; Diehl, G.; Rodrigues, M. J.; Guo, J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res., 2005, 4(2), 377-86.
25. Fernandez-Puente, P.; Mateos, J.; Fernandez-Costa, C.; Oreiro, N.; Fernandez-Lopez, C.; Ruiz-Romero, C.; Blanco, F. J. Identification of a panel of novel serum osteoarthritis biomarkers. J. Proteome Res. 2011, 10(11), 5095-101.
26. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics, 2002, 1(5), 376-86.
27. Calamia, V.; Rocha, B.; Mateos, J.; Fernandez-Puente, P.; Ruiz-Romero, C.; Blanco, F. J. Metabolic labeling of chondrocytes for the quantitative analysis of the interleukin-1-beta-mediated modulation of their intracellular and extracellular proteomes. J. Proteome Res., 2011, 10(8), 3701-11.
28. Rocha, B.; Calamia, V.; Mateos, J.; Fernandez-Puente, P.; Blanco, F.J.; Ruiz-Romero, C. Metabolic Labeling of Human Bone Marrow Mesenchymal Stem Cells for the Quantitative Analysis of their Chondrogenic Differentiation. J. Proteome Res., 2012, 11(11):5350-5361.
29. Kuhn, E.; Wu, J.; Karl, J.; Liao, H.; Zolg, W.; Guild, B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics, 2004, 4(4), 1175-86.
30. Haqqani, A. S.; Kelly, J. F.; Stanimirovic, D. B. Quantitative protein profiling by mass spectrometry using isotope-coded affinity tags. Methods Mol. Biol., 2008, 439, 225-40.
31. Marshall, A. G.; Hendrickson, C. L.; Jackson, G. S. Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom. Rev., 1998, 17(1), 1-35.
32. Hu, Q.; Noll, R. J.; Li, H.; Makarov, A.; Hardman, M.; Graham Cooks, R. The Orbitrap: a new mass spectrometer. J. Mass Spectrom., 2005, 40(4), 430-43.
33. Peterman, S. M.; Dufresne, C. P.; Horning, S. The use of a hybrid linear trap/FT-ICR mass spectrometer for on-line high resolution/high mass accuracy bottom-up sequencing. J. Biomol. Tech., 2005, 16(2), 112-24.
34. Nesvizhskii, A. I. Protein identification by tandem mass spectrometry and sequence database searching. Methods Mol. Biol., 2007, 367, 87-119.
35. Zhu, H.; Snyder, M. Protein chip technology. Curr. Opin. Chem. Biol., 2003, 7(1), 55-63.
36. rd. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine. Expert Rev. Mol. Diagn., 2007, 7(5), 625-33.
37. Robinson, W. H.; DiGennaro, C.; Hueber, W.; Haab, B. B.; Kamachi, M.; Dean, E. J.; Fournel, S.; Fong, D.; Genovese, M. C.; de Vegvar, H. E.; Skriner, K.; Hirschberg, D. L.; Morris, R. I.; Muller, S.; Pruijn, G. J.; van Venrooij, W. J.; Smolen, J. S.; Brown, P. O.; Steinman, L.; Utz, P. J. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med., 2002, 8(3), 295-301.
38. Hueber, W.; Utz, P. J.; Steinman, L.; Robinson, W. H. Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res., 2002, 4(5), 290-5.
39. Hueber, W.; Kidd, B. A.; Tomooka, B. H.; Lee, B. J.; Bruce, B.; Fries, J. F.; Sonderstrup, G.; Monach, P.; Drijfhout, J. W.; van Venrooij, W. J.; Utz, P. J.; Genovese, M. C.; Robinson, W. H. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum., 2005, 52(9), 2645-55.
40. O'Kane, S. L.; O'Brien, J. K.; Cahill, D. J. Optimized autoantibody profiling on protein arrays. Methods Mol. Biol., 2011, 785, 331-41.
41. Wu, W.; Slastad, H.; de la Rosa Carrillo, D.; Frey, T.; Tjonnfjord, G.; Boretti, E.; Aasheim, H. C.; Horejsi, V.; Lund-Johansen, F. Antibody array analysis with label-based detection and resolution of protein size. Mol. Cell. Proteomics, 2009, 8(2), 245-57.
42. de Seny, D.; Fillet, M.; Meuwis, M. A.; Geurts, P.; Lutteri, L.; Ribbens, C.; Bours, V.; Wehenkel, L.; Piette, J.; Malaise, M.; Merville, M. P. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-offlight mass spectrometry ProteinChip approach. Arthritis Rheum., 2005, 52(12), 3801-12.
43. de Seny, D.; Fillet, M.; Ribbens, C.; Maree, R.; Meuwis, M. A.; Lutteri, L.; Chapelle, J. P.; Wehenkel, L.; Louis, E.; Merville, M. P.; Malaise, M. Monomeric Calgranulins Measured by SELDI-TOF Mass Spectrometry and Calprotectin Measured by ELISA as Biomarkers in Arthritis. Clin. Chem., 2008, 54(6), 1066-75.
44. Dasuri, K.; Antonovici, M.; Chen, K.; Wong, K.; Standing, K.; Ens, W.; El-Gabalawy, H.; Wilkins, J. A. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res. Ther., 2004, 6(2), R161-8.
45. Lorenz, P.; Bantscheff, M.; Ibrahim, S. M.; Thiesen, H. J.; Glocker, M. O. Proteome analysis of diseased joints from mice suffering from collagen-induced arthritis. Clin. Chem. Lab. Med., 2003, 41(12), 1622-32.
46. Tilleman, K.; Van Beneden, K.; Dhondt, A.; Hoffman, I.; De Keyser, F.; Veys, E.; Elewaut, D.; Deforce, D. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics, 2005, 5(8), 2247-57.
47. Chang, X.; Cui, Y.; Zong, M.; Zhao, Y.; Yan, X.; Chen, Y.; Han, J. Identification of proteins with increased expression in rheumatoid arthritis synovial tissues. J. Rheumatol., 2009, 36(5), 872-80.
48. Bo, G. P.; Zhou, L. N.; He, W. F.; Luo, G. X.; Jia, X. F.; Gan, C. J.; Chen, G. X.; Fang, Y. F.; Larsen, P. M.; Wu, J. Analyses of differential proteome of human synovial fibroblasts obtained from arthritis. Clin. Rheumatol., 2009, 28(2), 191-9.
49. Zhang, H.; Fan, L. Y.; Zong, M.; Sun, L. S.; Lu, L. Proteins related to the functions of fibroblast-like synoviocytes identified by proteomic analysis. Clin. Exp. Rheumatol., 2012, 30(2), 213-21.
50. Wang, J. G.; Xu, W. D.; Zhai, W. T.; Li, Y.; Hu, J. W.; Hu, B.; Li, M.; Zhang, L.; Guo, W.; Zhang, J. P.; Wang, L. H.; Jiao, B. H. Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis: a comparative proteomics study. Arthritis Rheum., 2012, 64(4), 993-1004.
51. Katano, M.; Okamoto, K.; Arito, M.; Kawakami, Y.; Kurokawa, M. S.; Suematsu, N.; Shimada, S.; Nakamura, H.; Xiang, Y.; Masuko, K.; Nishioka, K.; Yudoh, K.; Kato, T. Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res. Ther., 2009, 11(1), R3.
52. Schulz, M.; Dotzlaw, H.; Mikkat, S.; Eggert, M.; Neeck, G. Proteomic analysis of peripheral blood mononuclear cells: selective protein processing observed in patients with rheumatoid arthritis. J. Proteome Res., 2007, 6(9), 3752-9.
53. Wang, L.; Dai, Y.; Qi, S.; Sun, B.; Wen, J.; Zhang, L.; Tu, Z. Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics. Rheumatol. Int., 2012, 32(3), 585-93.
54. Lu, M. C.; Lai, N. S.; Yu, H. C.; Huang, H. B.; Hsieh, S. C.; Yu, C. L. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production. Arthritis Rheum., 2010, 62(5), 1213-23.
55. Kastrinaki, M. C.; Sidiropoulos, P.; Roche, S.; Ringe, J.; Lehmann, S.; Kritikos, H.; Vlahava, V. M.; Delorme, B.; Eliopoulos, G. D.; Jorgensen, C.; Charbord, P.; Haupl, T.; Boumpas, D. T.; Papadaki, H. A. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann. Rheum. Dis., 2008, 67(6), 741-9.
56. Kamada, T.; Kurokawa, M. S.; Kato, T.; Takenouchi, K.; Takahashi, K.; Yoshioka, T.; Uchida, T.; Mitsui, H.; Suematsu, N.; Okamoto, K.; Yudo, K.; Katayama, Y.; Nakamura, H. Proteomic analysis of bone marrow-adherent cells in rheumatoid arthritis and osteoarthritis. Int. J. Rheum. Dis., 2012, 15(2), 169-78.
57. Niederberger, E.; Geisslinger, G. Analysis of NF-kappaB signaling pathways by proteomic approaches. Expert Rev. Proteomics., 2010, 7(2), 189-203.
58. Plenge, R. M. Recent progress in rheumatoid arthritis genetics: one step towards improved patient care. Curr. Opin. Rheumatol., 2009, 21(3), 262-71.
59. Lorenz, P.; Ruschpler, P.; Koczan, D.; Stiehl, P.; Thiesen, H. J. From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies. Proteomics, 2003, 3(6), 991-1002.
60. Klareskog, L.; Widhe, M.; Hermansson, M.; Ronnelid, J., Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr. Opin. Rheumatol., 2008, 20(3), 300-5.
61. Gibson, D. S.; Banha, J.; Penque, D.; Costa, L.; Conrads, T. P.; Cahill, D. J.; O'Brien, J. K.; Rooney, M. E. Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders. J. Proteomics, 2010, 73(6), 1045-60.
62. De Franceschi, L.; Bosello, S.; Scambi, C.; Biasi, D.; De Santis, M.; Caramaschi, P.; Peluso, G.; La Verde, V.; Bambara, L. M.; Ferraccioli, G. Proteome analysis of biological fluids from autoimmune-rheumatological disorders. Proteomics Clin. Appl., 2011, 5(1-2), 78-89.
63. Sinz, A.; Bantscheff, M.; Mikkat, S.; Ringel, B.; Drynda, S.; Kekow, J.; Thiesen, H. J.; Glocker, M. O. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis, 2002, 23(19), 3445-56.
64. Zheng, X.; Wu, S. L.; Hincapie, M.; Hancock, W. S. Study of the human plasma proteome of rheumatoid arthritis. J. Chromatogr. A, 2009, 1216(16), 3538-45.
65. Mateos, J.; Lourido, L.; Fernandez-Puente, P.; Calamia, V.; Fernandez-Lopez, C.; Oreiro, N.; Ruiz-Romero, C.; Blanco, F. J. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J. Proteomics, 2012, 75(10), 2869-2878.
66. Giusti, L.; Baldini, C.; Ciregia, F.; Giannaccini, G.; Giacomelli, C.; De Feo, F.; Delle Sedie, A.; Riente, L.; Lucacchini, A.; Bazzichi, L.; Bombardieri, S. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? Proteomics Clin. Appl., 2010, 4(3), 315-24.
67. van Schaardenburg, D.; Dijkmans, B. A. Clinical approaches to early inflammatory arthritis. Nat. Rev. Rheumatol., 2009, 5(11), 627-33.
68. Avouac, J.; Gossec, L.; Dougados, M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann. Rheum. Dis., 2006, 65(7), 845-51.
69. Tampoia, M.; Brescia, V.; Fontana, A.; Maggiolini, P.; Zucano, A.; Pansini, N. Proteomic: new advances in the diagnosis of rheumatoid arthritis. Clin. Chim. Acta, 2005, 357(2), 219-25.
70. Dotzlaw, H.; Schulz, M.; Eggert, M.; Neeck, G. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim. Biophys. Acta, 2004, 1696(1), 121-9.
71. De Ceuleneer, M.; Van Steendam, K.; Dhaenens, M.; Deforce, D. In vivo relevance of citrullinated proteins and the challenges in their detection. Proteomics, 2012, 12(6), 752-60.
72. Matsuo, K.; Xiang, Y.; Nakamura, H.; Masuko, K.; Yudoh, K.; Noyori, K.; Nishioka, K.; Saito, T.; Kato, T. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res. Ther., 2006, 8(6), R175.
73. Tabushi, Y.; Nakanishi, T.; Takeuchi, T.; Nakajima, M.; Ueda, K.; Kotani, T.; Makino, S.; Shimizu, A.; Hanafusa, T.; Takubo, T. Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysis. Ann. Clin. Biochem., 2008, 45(Pt 4), 413-7.
74. Raijmakers, R.; van Beers, J. J.; El-Azzouny, M.; Visser, N. F.; Bozic, B.; Pruijn, G. J.; Heck, A. J. Elevated levels of fibrinogenderived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res. Ther., 2012, 14(3), R114.
75. Goeb, V.; Thomas-L'Otellier, M.; Daveau, R.; Charlionet, R.; Fardellone, P.; Le Loet, X.; Tron, F.; Gilbert, D.; Vittecoq, O. Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res. Ther., 2009, 11(2), R38.
76. Saroha, A.; Biswas, S.; Chatterjee, B. P.; Das, H. R. Altered glycosylation and expression of plasma alpha-1-acid glycoprotein and haptoglobin in rheumatoid arthritis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2011, 879(20), 1839-43.
77. Baillet, A.; Trocme, C.; Berthier, S.; Arlotto, M.; Grange, L.; Chenau, J.; Quetant, S.; Seve, M.; Berger, F.; Juvin, R.; Morel, F.; Gaudin, P. Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford), 2010, 49(4), 671-82.
78. Niu, Q.; Huang, Z.; Shi, Y.; Wang, L.; Pan, X.; Hu, C. Specific serum protein biomarkers of rheumatoid arthritis detected by MALDI-TOF-MS combined with magnetic beads. Int. Immunol., 2010, 22(7), 611-8.
79. Long, L.; Li, R.; Li, Y.; Hu, C.; Li, Z. Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting. Rheumatol. Int., 2011, 31(8), 1069-74.
80. Zhang, X.; Yuan, Z.; Shen, B.; Zhu, M.; Liu, C.; Xu, W. Discovery of serum protein biomarkers in rheumatoid arthritis using MALDITOF-MS combined with magnetic beads. Clin. Exp. Med., 2012, 12(3), 145-51.
81. Chandra, P. E.; Sokolove, J.; Hipp, B. G.; Lindstrom, T. M.; Elder, J. T.; Reveille, J. D.; Eberl, H.; Klause, U.; Robinson, W. H. Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthritis Res. Ther., 2011, 13(3), R102.
82. Forslind, K.; Ahlmen, M.; Eberhardt, K.; Hafstrom, I.; Svensson, B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann. Rheum. Dis., 2004, 63(9), 1090-5.
83. Garnero, P.; Landewe, R.; Boers, M.; Verhoeven, A.; Van Der Linden, S.; Christgau, S.; Van Der Heijde, D.; Boonen, A.; Geusens, P. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum., 2002, 46(11), 2847-56.
84. Hueber, W.; Tomooka, B.; Zhao, X.; Kidd, B.; Drijfhout, J.; Fries, J.; van Venrooij, W.; Metzger, A.; Genovese, M.; Robinson, W. Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann. Rheum. Dis., 2007, 66(6), 712-9.
85. Liao, H.; Wu, J.; Kuhn, E.; Chin, W.; Chang, B.; Jones, M.; O'Neil, S.; Clauser, K.; Karl, J.; Hasler, F.; Roubenoff, R.; Zolg, W.; Guild, B. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum., 2004, 50(12), 3792-803.
86. Watanabe, J.; Charles-Schoeman, C.; Miao, Y.; Elashoff, D.; Lee, Y. Y.; Katselis, G.; Lee, T. D.; Reddy, S. T. Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis. Arthritis Rheum., 2012, 64(6), 1828-37.
87. Edwards, J. C.; Szczepanski, L.; Szechinski, J.; Filipowicz-Sosnowska, A.; Emery, P.; Close, D. R.; Stevens, R. M.; Shaw, T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid. N. Engl. J. Med., 2004, 350(25), 2572-81.
88. Drynda, S.; Ringel, B.; Kekow, M.; Kuhne, C.; Drynda, A.; Glocker, M. O.; Thiesen, H. J.; Kekow, J. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol. Res. Pract., 2004, 200(2), 165-71.
89. Hueber, W.; Tomooka, B. H.; Batliwalla, F.; Li, W.; Monach, P. A.; Tibshirani, R. J.; Van Vollenhoven, R. F.; Lampa, J.; Saito, K.; Tanaka, Y.; Genovese, M. C.; Klareskog, L.; Gregersen, P. K.; Robinson, W. H. Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Res. Ther., 2009, 11(3), R76.
90. Fabre, S.; Dupuy, A. M.; Dossat, N.; Guisset, C.; Cohen, J. D.; Cristol, J. P.; Daures, J. P.; Jorgensen, C. Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis. Clin. Exp. Immunol., 2008, 153(2), 188-95.
91. Fabre, S.; Guisset, C.; Tatem, L.; Dossat, N.; Dupuy, A. M.; Cohen, J. D.; Cristol, J. P.; Daures, J. P.; Jorgensen, C. Protein biochip array technology to monitor rituximab in rheumatoid arthritis. Clin. Exp. Immunol., 2009, 155(3), 395-402.
92. Sekigawa, I.; Yanagida, M.; Iwabuchi, K.; Kaneda, K.; Kaneko, H.; Takasaki, Y.; Jung, G.; Sone, S.; Tanaka, Y.; Ogawa, H.; Takamori, K. Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy. Clin. Exp. Rheumatol., 2008, 26(2), 261-7.
93. Trocme, C.; Marotte, H.; Baillet, A.; Pallot-Prades, B.; Garin, J.; Grange, L.; Miossec, P.; Tebib, J.; Berger, F.; Nissen, M. J.; Juvin, R.; Morel, F.; Gaudin, P. Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis. Ann. Rheum. Dis., 2009, 68(8), 1328-33.
94. Dwivedi, R. C.; Dhindsa, N.; Krokhin, O. V.; Cortens, J.; Wilkins, J. A.; El-Gabalawy, H. S. The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients. Arthritis Res. Ther., 2009, 11(2), R32.
95. Serada, S.; Fujimoto, M.; Ogata, A.; Terabe, F.; Hirano, T.; Iijima, H.; Shinzaki, S.; Nishikawa, T.; Ohkawara, T.; Iwahori, K.; Ohguro, N.; Kishimoto, T.; Naka, T. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann. Rheum. Dis., 2010, 69(4), 770-4.
96. Ortea, I.; Roschitzki, B.; Ovalles, J. G.; Longo, J. L.; de la Torre, I.; Gonzalez, I.; Gomez-Reino, J. J.; Gonzalez, A. Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis. J. Proteomics, 2012, 77, 372-82.
97. Lindstrom, T. M.; Robinson, W. H. Biomarkers for rheumatoid arthritis: making it personal. Scand. J. Clin. Lab. Invest. Suppl., 2010, 242, 79-84.
98. Scherer, H. U.; Dorner, T.; Burmester, G. R. Patient-tailored therapy in rheumatoid arthritis: an editorial review. Curr. Opin. Rheumatol., 2010, 22(3), 237-45.
99. Picotti, P.; Aebersold, R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods, 2012, 9(6), 555-66.
100. Kriegsmann, M.; Seeley, E. H.; Schwarting, A.; Kriegsmann, J.; Otto, M.; Thabe, H.; Dierkes, B.; Biehl, C.; Sack, U.; Wellmann, A.; Kahaly, G. J.; Schwamborn, K.; Caprioli, R. M. MALDI MS imaging as a powerful tool for investigating synovial tissue. Scand. J. Rheumatol., 2012, 41(4), 305-9.
101. Weljie, A. M.; Dowlatabadi, R.; Miller, B. J.; Vogel, H. J.; Jirik, F. R. An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. J. Proteome Res., 2007, 6(9), 3456-64.
102. Maecker, H. T.; Lindstrom, T. M.; Robinson, W. H.; Utz, P. J.; Hale, M.; Boyd, S. D.; Shen-Orr, S. S.; Fathman, C. G. New tools for classification and monitoring of autoimmune diseases. Nat. Rev. Rheumatol., 2012, 8(6), 317-28.
103. Lea, P.; Keystone, E.; Mudumba, S.; Kahama, A.; Ding, S. F.; Hansen, J.; Azad, A. A.; Wang, S.; Weber, D. Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX: planar microarray diagnosis. Clin. Rev. Allergy. Immunol., 2011, 41(1), 20-35.
104. Paik, Y. K.; Jeong, S. K.; Omenn, G. S.; Uhlen, M.; Hanash, S.; Cho, S. Y.; Lee, H. J.; Na, K.; Choi, E. Y.; Yan, F.; Zhang, F.; Zhang, Y.; Snyder, M.; Cheng, Y.; Chen, R.; Marko-Varga, G.; Deutsch, E. W.; Kim, H.; Kwon, J. Y.; Aebersold, R.; Bairoch, A.; Taylor, A. D.; Kim, K. Y.; Lee, E. Y.; Hochstrasser, D.; Legrain, P.; Hancock, W. S. The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat. Biotechnol., 2012, 30(3), 221-3.